Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,605 USD | -0,09% | -15,20% | -44,92% |
Vakgebied
Aantal werknemers: 265
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Genome Editing Technology
100,0
%
| 20 | 100,0 % | 78 | 100,0 % | +296,32% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 20 | 100,0 % | 78 | 100,0 % | +296,32% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 01-06-22 |
Erick Lucera
DFI | Director of Finance/CFO | 57 | 17-05-23 |
Linda Burkly
CTO | Chief Tech/Sci/R&D Officer | - | 24-07-23 |
Mei Baisong
CTO | Chief Tech/Sci/R&D Officer | 60 | 18-07-22 |
Chi Li
LAW | General Counsel | - | 14-06-21 |
Linea Aspesi
HRO | Human Resources Officer | - | 01-02-23 |
Charlene Stern
LAW | General Counsel | - | 01-01-13 |
Kate X. Zhang
PRN | Corporate Officer/Principal | - | 01-10-18 |
Caren Deardorf
PRN | Corporate Officer/Principal | 59 | 26-09-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Emma Reeve
CHM | Chairman | 63 | 03-09-21 |
David Scadden
BRD | Director/Board Member | 71 | 06-02-19 |
Akshay Vaishnaw
BRD | Director/Board Member | 61 | 28-07-16 |
Andrew Hirsch
BRD | Director/Board Member | 53 | 30-05-17 |
Jessica Hopfield
BRD | Director/Board Member | 59 | 16-02-18 |
Elliott Levy
BRD | Director/Board Member | 64 | 11-04-23 |
Director/Board Member | 65 | 26-10-21 | |
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 01-06-22 |
Meeta Chatterjee
BRD | Director/Board Member | 69 | 17-12-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 82 234 710 | 81 066 427 ( 98,58 %) | 0 | 98,58 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-44,92% | 461 mln. | |
-2,30% | 41,36 mld. | |
+44,25% | 41,3 mld. | |
+3,24% | 39,61 mld. | |
-12,11% | 25,62 mld. | |
+3,00% | 24,09 mld. | |
-24,26% | 18,38 mld. | |
+22,44% | 11,85 mld. | |
-3,90% | 11,82 mld. | |
+7,81% | 11,07 mld. |
- Beurs
- Aandelen
- Koers EDIT
- Onderneming Editas Medicine, Inc.